AI coaches doctors on cancer risk talks

NCT ID NCT05923684

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This pilot study tests whether giving doctors and patients feedback from AI analysis of their consultations can improve how prostate cancer risks are communicated. Men newly diagnosed with localized prostate cancer will have their initial treatment consultations recorded. An AI system will extract key statements about prognosis, life expectancy, and side effects, and both patients and doctors will receive feedback within two weeks. The goal is to see if this feedback reduces patient uncertainty and improves risk understanding, potentially leading to better shared decision-making.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Natural language processing (NLP)-based feedback on consultation recordings
What this could lead to
If successful, this approach could improve how doctors explain risks and options to men with prostate cancer, leading to more informed treatment decisions.
What could go wrong
This is a small pilot study with only 30 participants, so results may not apply broadly. The feedback system depends on English-language recordings and may not capture all nuances of communication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.